| 5.35 Data as of 3:58pm ET | +0.14 / +2.69%Today’s Change | 4.20 Today|||52-Week Range 8.53 | -22.01% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $175.7M |
Company Description
Nymox Pharmaceutical Corp. is a biopharmaceutical company. The company is engaged in the research and development of therapeutics and diagnostics with a particular emphasis on products targeted for the unmet needs of the aging population. It offers NicAlert and TobacAlert tests for measuring tobacco product exposure and AlzheimAlert, a test to aid in the diagnosis of Alzheimer's disease. Nymox Pharmaceutical was founded by Paul Averback in May 30, 1995 and is headquartered in St. Laurent, Canada.
Employees

Shareholders
| Other institutional | 1.29% |
| Mutual fund holders | 0.24% |
| Individual stakeholders | -- |
Top Executives
| Paul Averback, MD | Chairman, President & Chief Executive Officer |
| Roy M. Wolvin | Chief Financial Officer, Secretary & Treasurer |
| Jack Gemmell | Director & Chief Information Officer |
| Brian Doyle, MBA | Director-Business Development |